Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) — Strategic Asset Allocation Index
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) has a Strategic Asset Allocation Index of 19.3% as of June 2023. Strategic assets (PP&E of CN¥2.12 Billion plus long-term investments of CN¥-) total CN¥2.12 Billion, measured against net assets of CN¥10.98 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Jiangsu Yuyue Medical Equipment & Supply liquidity resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Jiangsu Yuyue Medical Equipment & Supply Co Ltd Strategic Asset Allocation Index (2005–2022)
This chart shows how Jiangsu Yuyue Medical Equipment & Supply Co Ltd's Strategic Asset Allocation Index has evolved across 18 annual periods from 2005 to 2022. As of June 2023, the index stands at 19.3%, representing strategic assets of CN¥2.12 Billion against net assets of CN¥10.98 Billion CNY. See how financially flexible is Jiangsu Yuyue Medical Equipment & Supply to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Jiangsu Yuyue Medical Equipment & Supply Co Ltd (2005–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Jiangsu Yuyue Medical Equipment & Supply Co Ltd from 2005 to 2022, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Jiangsu Yuyue Medical Equipment & Supply stock valuation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 21.6% | CN¥2.17 Billion | CN¥2.17 Billion | CN¥- | CN¥10.07 Billion | ▼ -2.2 pp |
| 2021 | 23.8% | CN¥2.00 Billion | CN¥2.00 Billion | CN¥- | CN¥8.43 Billion | ▼ -1.1 pp |
| 2020 | 24.8% | CN¥1.86 Billion | CN¥1.86 Billion | CN¥- | CN¥7.49 Billion | ▼ -3.9 pp |
| 2019 | 28.7% | CN¥1.77 Billion | CN¥1.77 Billion | CN¥- | CN¥6.16 Billion | ▲ +2.4 pp |
| 2018 | 26.3% | CN¥1.46 Billion | CN¥1.16 Billion | CN¥291.65 Million | CN¥5.54 Billion | ▲ +6.6 pp |
| 2017 | 19.6% | CN¥1.09 Billion | CN¥881.86 Million | CN¥212.62 Million | CN¥5.57 Billion | ▲ +7.0 pp |
| 2016 | 12.6% | CN¥623.18 Million | CN¥515.10 Million | CN¥108.08 Million | CN¥4.94 Billion | ▼ -13.2 pp |
| 2015 | 25.8% | CN¥551.04 Million | CN¥463.26 Million | CN¥87.78 Million | CN¥2.13 Billion | ▲ +1.5 pp |
| 2014 | 24.4% | CN¥428.99 Million | CN¥428.99 Million | CN¥- | CN¥1.76 Billion | ▼ -7.6 pp |
| 2013 | 32.0% | CN¥485.30 Million | CN¥485.30 Million | CN¥- | CN¥1.52 Billion | ▲ +0.3 pp |
| 2012 | 31.7% | CN¥416.12 Million | CN¥416.12 Million | CN¥- | CN¥1.31 Billion | ▼ -3.5 pp |
| 2011 | 35.3% | CN¥390.64 Million | CN¥390.64 Million | CN¥- | CN¥1.11 Billion | ▼ -0.6 pp |
| 2010 | 35.9% | CN¥315.30 Million | CN¥315.30 Million | CN¥- | CN¥879.47 Million | ▼ -17.5 pp |
| 2009 | 53.3% | CN¥257.31 Million | CN¥257.31 Million | CN¥- | CN¥482.51 Million | ▲ +10.7 pp |
| 2008 | 42.6% | CN¥173.03 Million | CN¥173.03 Million | CN¥- | CN¥405.69 Million | ▼ -64.5 pp |
| 2007 | 107.2% | CN¥146.85 Million | CN¥146.85 Million | CN¥- | CN¥137.01 Million | ▲ +68.6 pp |
| 2006 | 38.6% | CN¥59.55 Million | CN¥59.55 Million | CN¥- | CN¥154.18 Million | ▲ +22.6 pp |
| 2005 | 16.1% | CN¥23.08 Million | CN¥23.08 Million | CN¥- | CN¥143.67 Million | — |